# Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses

Study · id `cardio:ct-nct02936622` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02936622](<https://clinicaltrials.gov/study/NCT02936622>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02936622

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 176 participants.

## Technical summary

Registry record NCT02936622. Randomized; single masking; primary purpose treatment. Start 2017-02-21 (actual); primary completion 2019-04-23 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 176 participants (enrolled count; ClinicalTrials.gov record NCT02936622, source copy `cardio:ctgov-nct02936622-2024-04-05`, retrieved 2026-10-31)
- Started: 2017-02-21 (actual) (ClinicalTrials.gov record NCT02936622, source copy `cardio:ctgov-nct02936622-2024-04-05`, retrieved 2026-10-31)
- Primary completion: 2019-04-23 (actual) (ClinicalTrials.gov record NCT02936622, source copy `cardio:ctgov-nct02936622-2024-04-05`, retrieved 2026-10-31)
- Completion: 2023-10-25 (actual) (ClinicalTrials.gov record NCT02936622, source copy `cardio:ctgov-nct02936622-2024-04-05`, retrieved 2026-10-31)
- Countries: Germany; New Zealand (ClinicalTrials.gov record NCT02936622, source copy `cardio:ctgov-nct02936622-2024-04-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02936622-2024-04-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses
- Acronym: XPEDITE
- Condition: Peripheral Arterial Disease (PAD)
- Intervention (Device): Zilver® Paclitaxel-Eluting Peripheral Stent
- Intervention (Device): Zilver® Paclitaxel-Eluting Peripheral Stent with slower-dissolving polymer-free paclitaxel coating
- Intervention (Device): Zilver® Paclitaxel-Eluting Peripheral Stent with higher-dose polymer-free paclitaxel coating
- Lead sponsor: Cook Group Incorporated
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Cook Group Incorporated (`cardio:org-cook-group-incorporated`)

## Provenance

Content hash: fa56b52772e8b916bddb1a633dd6e6d89037a233fb5347c026c7f99ecf3eabfb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
